Pelthos Therapeutics Inc. (PTHS) Live Share Price, Invest From India

Pelthos Therapeutics Inc. Stock Performance

as on May 14, 2026 at 2:15 pm IST

Day's Low
Day's High
$26.10
Day's Price Range
$29.64
$26.01
-0.35%
Downside
13.96%
Upside
52 Week's Low
52 Week's High
$13.76
52-Week Price Range
$54.29
$26.01
47.10%
Downside
108.73%
Upside

Pelthos Therapeutics Inc. share price movements today

Previous Close: $27.24
Open: $27.05
Volume: 120.3K
Day's Low - High: $26.10 - $29.64
52 Week Low - High: $13.76 - $54.29

Pelthos Therapeutics Inc. Historical Returns

1 Month Return: + 18.43 %
3 Month Return: + 32.37 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Pelthos Therapeutics Inc. Stock Fundamentals & Key Indicators

Check Pelthos Therapeutics Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$90.1M

EPS (TTM)

-10.9533

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

Return On Equity TTM

-239.55%

Pelthos Therapeutics Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Pelthos Therapeutics Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Pelthos Therapeutics Inc.	NA	$90.1M	NA	NA	-257.93%
Alnylam Pharmaceuticals Inc	BUY	$38.0B	115.2%	71.39	12.55%
BeiGene, Ltd.	NA	$32.7B	NA	71.44	8.94%
Vertex Pharmaceuticals Inc	BUY	$110.4B	106.5%	25.84	35.51%
Regeneron Pharmaceuticals Inc	BUY	$74.7B	40.03%	17.39	29.65%

Indian Investors' Interest in Pelthos Therapeutics Inc. Stock

Search interest for Pelthos Therapeutics Inc. Stock has decreased by -31% in the last 30 days, reflecting a downward trend in search activity.

Time period: April 14, 2026 to May 14, 2026

Change:-31% versus previous 30 day period

Pelthos Therapeutics Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	-	-	-	-	-	-	7	9
Gross Profit	-	-	-	-	-	-	4	6
Operating Income	-1	-1	-2	-1	-1	-3	-15	-12
EBITDA	-1	-1	-1	-1	-1	-3	-14	-10
Interest Expense	0	0	0	0	0	0	1	1
Depreciation	-	-	-	-	-	-	2	1
Income Before Tax	-2	-1	-1	-1	-1	-3	-16	-28
Income Tax Expense	-	-	-	-	-	-	0	-6
Net Income	-2	-1	-1	-1	-1	-3	-16	-21
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-219.25%	-230.74%

Pelthos Therapeutics Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	0	-	-	-	-	16
Gross Profit	0	-	-	-	-	10
Operating Income	-1	0	-2	-6	-7	-32
EBITDA	0	0	-2	-6	-7	-30
Interest Expense	0	0	0	0	0	3
Depreciation	-	-	-	-	-	2
Income Before Tax	0	0	-2	-7	-7	-50
Income Tax Expense	-	-	-	-	-	-7
Net Income	0	0	-2	-7	-7	-43
Net Profit Margin	-330.40%	0.00%	0.00%	0.00%	0.00%	-257.93%

Pelthos Therapeutics Inc. Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Net Income	-2	-1	-1	-1	-1	-3	-16	-21
Operating Cash Flow	-1	-2	0	0	0	0	-15	-6
Investing Cash Flow	-	-	-	-	-	-	2	-7
Financing Cash Flow	5	1	0	0	0	0	26	18
Change in Cash	3	-1	-1	0	0	0	14	3

Pelthos Therapeutics Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-2	-7	-7	-43
Operating Cash Flow	-1	0	-5	-22
Investing Cash Flow	-	-	-	-5
Financing Cash Flow	1	1	6	45
Change in Cash	0	0	0	17

Insights on Pelthos Therapeutics Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 1 year, PTHS stock has moved up by 2469.8%
POSITIVE IMPACT
Best in 1 Year
In the last 1 year, PTHS has outperformed top 5 stocks with highest market-cap in its industry

About Pelthos Therapeutics Inc.

Pelthos Therapeutics Inc., a bio-pharmaceutical company, develops and commercializes therapeutic products to help patients with unmet treatment burdens. The company offers ZELSUVMI for the treatment of molluscum contagiosum in adults and children 1 year of age and older; XEPI, (ozenoxacin) cream, a quinolone antimicrobial for the treatment of impetigo due to Staphylococcus aureus or Streptococcus pyogenes in adult and pediatric patients 2 months of age and older; and XEGLYZE, a pediculicide indicated for topical treatment of head lice infestation in patients 6 months of age and older. It also provides NITRICIL, a proprietary nitric oxide-based technology platform. The company was formerly known as Channel Therapeutics Corporation and changed its name to Pelthos Therapeutics Inc. in July 2025. Pelthos Therapeutics Inc. was founded in 2002 and is based in Durham, North Carolina.

Organisation	Pelthos Therapeutics Inc.
Headquarters	4020 Stirrup Creek Drive, Durham, NC, United States, 27703
Industry	Biotechnology
CEO	Mr. Scott M. Plesha
E-voting on shares	Click here to vote

Key Management of Pelthos Therapeutics Inc.

Name	Title
Mr. Scott M. Plesha	CEO, President & Director
Mr. Sai Rangarao M.B.A.	Chief Commercial Officer
Mr. John M. Gay CPA	CFO, Treasurer & Secretary

FAQs

What is Pelthos Therapeutics Inc. share price today?

Pelthos Therapeutics Inc. share price today is $26.01 as on May 14, 2026 at 8:45 am IST at the close of the market. Pelthos Therapeutics Inc. share today touched a day high of $29.64 and a low of $26.1.

What is the 52 week high and 52 week low for Pelthos Therapeutics Inc. share?

Pelthos Therapeutics Inc. share touched a 52 week high of $54.29 on July 7, 2025 and a 52 week low of $13.76 on July 2, 2025. Pelthos Therapeutics Inc. stock price today i.e. May 14, 2026 at 8:45 am IST is closed at $26.01,which is 52.09% down from its 52 week high and 89.03% up from its 52 week low.

What is Pelthos Therapeutics Inc.'s market capitalisation today?

Pelthos Therapeutics Inc. market capitalisation is $0.00T as on May 14, 2026 at 8:45 am IST.

How to invest in Pelthos Therapeutics Inc. Stock (PTHS) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Pelthos Therapeutics Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Pelthos Therapeutics Inc. Shares that will get you 0.0577 shares as per Pelthos Therapeutics Inc. share price of $26.01 per share as on May 14, 2026 at 8:45 am IST.

What is the minimum amount required to buy Pelthos Therapeutics Inc. Stock (PTHS) from India?

Indian investors can start investing in Pelthos Therapeutics Inc. (PTHS) shares with as little as ₹95.705 or $1 (as of May 14, 2026 at 2:47 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹957.05 in Pelthos Therapeutics Inc. stock (as per the Rupee-Dollar exchange rate as on May 14, 2026 at 2:47 pm IST). Based on Pelthos Therapeutics Inc. share’s latest price of $26.01 as on May 14, 2026 at 8:45 am IST, you will get 0.3845 shares of Pelthos Therapeutics Inc.. Learn more about fractional shares .